RMFEX
Price
$60.79
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
SWDSX
Price
$17.39
Change
+$0.05 (+0.29%)
Updated
Jul 25 closing price
Net Assets
564.17M
Interact to see
Advertisement

RMFEX vs SWDSX

Header iconRMFEX vs SWDSX Comparison
Open Charts RMFEX vs SWDSXBanner chart's image
American Funds American Mutual R4
Price$60.79
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
Schwab Dividend Equity
Price$17.39
Change+$0.05 (+0.29%)
VolumeN/A
Net Assets564.17M
RMFEX vs SWDSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RMFEX vs. SWDSX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a Buy and SWDSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 111B vs. SWDSX (564M). SWDSX pays higher dividends than RMFEX: SWDSX (1.78) vs RMFEX (1.53). RMFEX was incepted earlier than SWDSX: RMFEX (23 years) vs SWDSX (22 years). SWDSX (0.89) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. SWDSX (12.00). SWDSX has a lower initial minimum investment than RMFEX: SWDSX (0) vs RMFEX (250). SWDSX annual gain was more profitable for investors over the last year : 14.94 vs. RMFEX (11.74). RMFEX return over 5 years is better than : 62.99 vs. SWDSX (50.84).
RMFEXSWDSXRMFEX / SWDSX
Total Expense Ratio0.620.8970%
Annual Report Gross Expense Ratio0.620.8970%
Fund Existence23 years22 years-
Gain YTD11.5278.524135%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets111B564M19,681%
Annual Yield % from dividends1.531.7886%
Returns for 1 year11.7414.9479%
Returns for 3 years32.0833.2097%
Returns for 5 years62.9950.84124%
Returns for 10 years88.9613.28670%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
ESPR1.510.02
+1.34%
Esperion Therapeutics
BMRN59.01-0.75
-1.26%
BioMarin Pharmaceutical
TOUR0.86-0.02
-2.16%
Tuniu Corp
IMTE1.15-0.11
-8.73%
Integrated Media Technology Limited